The pharmaceutical company said, “The allegations that came out in the media are entirely baseless, distorted, and part of a smear campaign" ...

Thanks to the spending growth cap, the U.K. government in December 2024 announced that companies would need to pay a 22.9% ...

Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor ...

The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...

Sarepta will update Elevidys’ label after a patient died following treatment; the FDA issues flu vaccine recommendations ...

The FDA gave Pfizer's RSVpreF (PF-06928316) vaccine the new status – which ... against RSV in the crucial first few months of life. AstraZeneca and Sanofi are leading the charge here with ...

After rejecting Pfizer, AstraZeneca continued with its own M ... and prevent widespread economic disruption was to produce a vaccine against the SARS-COV-2 coronavirus that causes the disease.

The "Inhalable Biologics Market Size, Share & Trends Analysis Report by Biologics (Peptides & Proteins, Monoclonal Antibodies ...

The government has identified life sciences as one of the sectors with the highest potential for growth in the UK and plans to make it a key pillar of its upcoming industry strategy. The ...

Consultants assessing Covid vaccine damage claims on behalf of the NHS have been paid millions more than the victims, it has ...

The future of the life sciences industry hinges on AI and automation, driving innovation in drug discovery and addressing ...

From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 million upfront, building out another cancer-targeting approach.